Synapse - National Cancer Institute

National Cancer Institute

SHERPA: Unknown

People

Bosl
Motzer

Groups

Search Within

Results (4)

Export to EndNote / Excel

Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin

Journal Article

Motzer, R. J.; Bosl, G. J.; Tauer, K.; Golbey, R.
Cancer Treatment Reports (1987)

Fulltext@MSK | Save

Phase II trial of mitoguazone in patients with refractory germ cell tumors

Journal Article

Chun, H.; Bosl, G. J.
Cancer Treatment Reports (1985)

Fulltext@MSK | Save

Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors

Journal Article

Chun, H.; Bosl, G. J.; Golbey, R. B.
Cancer Treatment Reports (1985)

Fulltext@MSK | Save

Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin

Journal Article

Magee, M. J.; Howard, J.; Bosl, G. J.; Wittes, R. E.
Cancer Treatment Reports (1985)

Fulltext@MSK | Save

National Cancer Institute – authorized name for: